News

Hugo Boss Eyewear Presents Architectural Design Combinations

Transferring the combination of nature and architectural design, these feminine acetate sunglasses are embellished by a wood effect insert on the temples, featuring light cat-eye, oversized and round shapes.

Read More

Eyelash Mites the Subject of CLU Issue 29

Issue 29 of Contact Lens Update, published by the Centre for Contact Lens Research (CCLR), University of Waterloo, features articles on the parasitic eyelash mites known as Demodex

Read More

Fabrizio Uguzzoni to Replace Holly Rush at Luxottica

As reported in VMail on Monday December 14, Holly Rush will leave Luxottica Wholesale North America at the end of the year, five years almost to the day after being appointed chair.

Read More

Modern Luxury. Sensual Purity. Mercedes-Benz Style.

Progressive design and flawless functionality are the hallmarks of the 2015 autumn/winter collection designed by Mercedes-Benz Style and Rodenstock.

Read More

Johns Hopkins Researchers Grow Retinal Nerve Cells

In what is hoped to be an important step on the path towards cell transplants for patients with glaucoma or multiple sclerosis, researchers at Johns Hopkins University have developed a method of developing retinal ganglion cells from human stem cells.

Read More

WestGroupe Launches FYSH UK Sunwear to the World

The new Links collection was created and designed with precision, passion and creativity resulting in a 24-piece collection that every woman will adore.

Read More

Transitions Research: Are You Underserving Multicultural Patients?

Survey Identifies Need for Staff Diversity Training, Bilingual and In-language Materials and More.

Read More

Orgreen Finds its Inspiration Everywhere

ORGREEN OPTICS is known for its innovative approach to design, choice of materials, stylistic signature and combination of original colours.

Read More

Anti-epileptic Drug Study to Reveal Scope of Potential Serious Vision Side Effects

The anti-epileptic drug vigabatrin, sold under the brand name Sabril, has as a side effect of mild to severe vision problems and possible permanent loss of vision.

Read More

Pharmaceutical Company Acquires Merck’s Glaucoma Portfolio

Mundipharma Ophthalmology Products Limited announced an agreement with Merck to acquire their ophthalmology portfolio for the treatment of increased ocular pressure caused by open angle glaucoma for Canada and other markets outside of the United States.

Read More